Leonardo Guedes Andrade

Dr. Leonardo Guedes Andrade

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
LALeonardo Guedes Andrade
Leonardo Guedes Andrade
VPValerio Portela
Valerio Portela
ESEsdras Corrêa Dos Santos
Esdras Corrêa Dos Santos
KAKarine de Vargas Aires
Karine de Vargas Aires
RFRogério Ferreira
Rogério Ferreira
GZGustavo Zamberlam
Gustavo Zamberlam
The molecular mechanisms that drive the granulosa cells’ (GC) differentiation into a more estrogenic phenotype during follicular divergence and establishment of follicle dominance have not been completely elucidated. The main Hippo signaling effector, YAP, has, however, emerged as a potential key player to explain such complex processes. Studies using rat and bovine GC demonstrate that, in conditions where the expression of the classic YAP-TEAD target gene tissue growth factor (CTGF) is augmented, CYP19A1 expression and activity and, consequently, estradiol (E2) secretion are reduced. These findings led us to hypothesize that, during ovarian follicular divergence in cattle, FSH downregulates YAP-TEAD-dependent transcriptional activity in GC to allow the future dominant follicle to exert its augmented estrogenic capacity. To address this, we performed a series of experiments employing distinct bovine models. Our in vitro and ex vivo experiments indicated that indeed FSH downregulates, in a concentration-dependent manner, mRNA levels not only for CTGF but also for the other classic YAP-TEAD transcriptional target genes ANKRD1 and CYR61 by a mechanism that involves increased YAP phosphorylation. To better elucidate the functional importance of such FSH-induced YAP activity regulation, we then cultured GC in the presence of verteporfin (VP) or peptide 17 (P17), two pharmacological inhibitors known to interfere with YAP binding to TEADs. The results showed that both VP and P17 increased CYP19A1 basal mRNA levels in a concentration-dependent manner. Most interestingly, by using GC samples obtained in vivo from dominant vs. subordinate follicles, we found that mRNA levels for CTGF, CYR61, and ANKRD1 are higher in subordinate follicles following the follicular divergence. Taken together, our novel results demonstrate that YAP transcriptional activity is regulated in bovine granulosa cells to allow the increased estrogenic capacity of the selected dominant follicle.

27 August 2025 in Animals
Verified
Journal Article
Open access
PDF file
KAKarine de Vargas Aires
Karine de Vargas Aires
ASAna Paula da Silva
Ana Paula da Silva
LALeonardo Guedes Andrade
Leonardo Guedes Andrade
ABAlexandre Boyer
Alexandre Boyer
GZGustavo Zamberlam
Gustavo Zamberlam
Guillaume St-JeanGuillaume St-Jean
Guillaume St-Jean
Postpartum uterine involution in cattle involves complex morphological and immunological changes essential for restoring uterine health and fertility. This study evaluated endometrial biopsies collected at four postpartum time points to characterize tissue remodeling and immune cell dynamics during involution. Histology revealed intact luminal columnar epithelium in 92.98% of samples, with stable stromal architecture. Stromal edema decreased by Day 7 but increased again by Day 35, while endometrial gland numbers significantly rose at Day 35, suggesting glandular recovery linked to resumed cyclicity. Subepithelial collagen deposition peaked on Day 21, indicating active extracellular matrix remodeling. Immunologically, early postpartum was marked by increased PMNs and macrophages, whereas Day 21 showed peak infiltration of natural killer (NK) cells and T and B lymphocytes, sometimes forming lymphoid aggregates. Manual and automated immune cell quantifications correlated well. These findings demonstrate a dynamic shift from acute neutrophil-dominated inflammation to a lymphocyte-rich environment during uterine involution. This immune modulation may contribute to the earlier diagnosis of subclinical endometritis, typically identified at later stages of postpartum period. Overall, this study provides insight into the temporal immunomorphological events supporting uterine recovery, with potential implications for reproductive management in dairy cattle.

18 August 2021 in Zygote
Verified
Journal Article
Closed access
PDF file
ESElisabeth Schmidt da Silva
Elisabeth Schmidt da Silva
CACarolina Amaral
Carolina Amaral
MBMarcos Barreta
Marcos Barreta
AAAlfredo Antoniazzi
Alfredo Antoniazzi
LALeonardo Guedes Andrade
Leonardo Guedes Andrade
PGPaulo Bayard Dias Goncalves
Paulo Bayard Dias Goncalves
The Hippo pathway is involved in the proliferation of intrafollicular cells and in early embryonic development, mainly because effectors of this pathway are key transcription regulators of genes such as CTGF and CYR61, which are involved in cell proliferation. Recent studies by our group found that fibroblast growth factor 18 (FGF18) is present in the fallopian tube during early embryonic development, leading to the hypothesis that FGF18 may have a role during embryonic development. Therefore, the aim of the following study was to determine whether FGF18 modulates the expression of Hippo pathway target genes, CTGF and CYR61, during oocyte maturation and early embryonic development. Three experiments were carried out, with in vitro maturation (IVM) of cumulus–oocyte complexes (COCs) and embryo culture. In experiment one, FGF18 (100 ng/ml) induced an increase (P < 0.05) in CTGF gene expression at 12 h post-exposure. In experiment two, FGF18 (100 ng/ml) induced a reduction (P < 0.05) in CTGF expression at 3 h post-exposure. In the third experiment, day 7 embryos exposed to FGF18 during oocyte IVM expressed greater CTGF mRNA abundance, whereas FGF18 exposure during embryo in vitro embryo culture did not alter CTGF expression in comparison with untreated controls. The preliminary data presented here show that FGF18 modulates CTGF expression in critical periods of oocyte nuclear maturation, cumulus expansion and early embryonic development in cattle.

9 October 2025 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
GBGerson Fernandes de Brum
Gerson Fernandes de Brum
ELElisa Piton Lovis
Elisa Piton Lovis
TFTuyla Fontana
Tuyla Fontana
LPLauren Pappis
Lauren Pappis
TMTaíse Regina Schuster Montagner
Taíse Regina Schuster Montagner
GBGuilherme Bochi
Guilherme Bochi

17 October 2025 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
LALeonardo Guedes Andrade
Leonardo Guedes Andrade
VPValério Marques Portela
Valério Marques Portela
KAKarine de Vargas Aires
Karine de Vargas Aires
NJNatalia Jakuc
Natalia Jakuc
ASAna Paula da Silva
Ana Paula da Silva
GZGustavo Zamberlam
Gustavo Zamberlam

2 January 2026 in Revista Contexto & Saúde
Verified
Journal Article
Open access
GSGregory Klein Schneider
Gregory Klein Schneider
FAFrancini Arboit
Francini Arboit
VSVitória Schnath
Vitória Schnath
GBGuilherme Bochi
Guilherme Bochi
MPMaria A. Pavanato
Maria A. Pavanato
EZEliane Maria Zanchet
Eliane Maria Zanchet
Major depressive disorder is a reality to an increasing number of individuals worldwide, yet, it is still poorly understood and its treatment remains lackluster. Due to the subpar success rates of traditional monoaminergic pharmacotherapy, new targets have been explored. Here, the behavioral effects of a single dose of moxidectin (MOX) (1,5 mg/kg, 0,1 mL/10g, s.c.), a drug capable of allosterically modulating GABAA channels, was evaluated in male Swiss mice by the tail suspension (TST), splash (SPT), open field and elevated plus maze tests between 24 and 48 h post injection. MOX was capable of significantly decreasing the immobility time in TST and increasing grooming time in SPT, suggesting an antidepressant effect. To further explain the molecular pathways underlying MOX's observed behavioral changes, neurotrophic factors and oxidative stress biomarkers were identified. An increase in brain-derived neurotrophic factor (Bdnf) mRNA was observed, possibly explaining the behavioral changes. An increase in total antioxidant capacity and glutathione S-transferase (GST) in the prefrontal cortex and a decrease of GST in the hippocampus of MOX-treated animals may have also contributed to these results. To our knowledge, this is the first study demonstrating the antidepressant-like effect of MOX in mice. While these results are preliminary, they’re promising. The utilization of GABAA modulators is an emerging and interesting new avenue to be explored in the treatment of neuropsychiatric ailments.